Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

91 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Dose-intensive response-based chemotherapy and radiation therapy for children and adolescents with newly diagnosed intermediate-risk hodgkin lymphoma: a report from the Children's Oncology Group Study AHOD0031.
Friedman DL, Chen L, Wolden S, Buxton A, McCarten K, FitzGerald TJ, Kessel S, De Alarcon PA, Chen AR, Kobrinsky N, Ehrlich P, Hutchison RE, Constine LS, Schwartz CL. Friedman DL, et al. Among authors: de alarcon pa. J Clin Oncol. 2014 Nov 10;32(32):3651-8. doi: 10.1200/JCO.2013.52.5410. Epub 2014 Oct 13. J Clin Oncol. 2014. PMID: 25311218 Free PMC article. Clinical Trial.
POG 8625: a randomized trial comparing chemotherapy with chemoradiotherapy for children and adolescents with Stages I, IIA, IIIA1 Hodgkin Disease: a report from the Children's Oncology Group.
Kung FH, Schwartz CL, Ferree CR, London WB, Ternberg JL, Behm FG, Wharam MD, Falletta JM, de Alarcon P, Chauvenet AR; Children's Oncology Group. Kung FH, et al. J Pediatr Hematol Oncol. 2006 Jun;28(6):362-8. doi: 10.1097/00043426-200606000-00008. J Pediatr Hematol Oncol. 2006. PMID: 16794504 Clinical Trial.
Response-dependent and reduced treatment in lower risk Hodgkin lymphoma in children and adolescents, results of P9426: a report from the Children's Oncology Group.
Tebbi CK, Mendenhall NP, London WB, Williams JL, Hutchison RE, Fitzgerald TJ, de Alarcón PA, Schwartz C, Chauvenet A. Tebbi CK, et al. Among authors: de alarcon pa. Pediatr Blood Cancer. 2012 Dec 15;59(7):1259-65. doi: 10.1002/pbc.24279. Epub 2012 Aug 21. Pediatr Blood Cancer. 2012. PMID: 22911615 Free PMC article. Clinical Trial.
Childhood Hodgkin International Prognostic Score (CHIPS) Predicts event-free survival in Hodgkin Lymphoma: A Report from the Children's Oncology Group.
Schwartz CL, Chen L, McCarten K, Wolden S, Constine LS, Hutchison RE, de Alarcon PA, Keller FG, Kelly KM, Trippet TA, Voss SD, Friedman DL. Schwartz CL, et al. Among authors: de alarcon pa. Pediatr Blood Cancer. 2017 Apr;64(4):10.1002/pbc.26278. doi: 10.1002/pbc.26278. Epub 2016 Oct 27. Pediatr Blood Cancer. 2017. PMID: 27786406 Free PMC article.
Outcome of adolescents and young adults compared to children with Hodgkin lymphoma treated with response-based chemotherapy on pediatric protocols: A Children's Oncology Group report.
Fernández KS, Schwartz CL, Chen L, Constine LS, Chauvenet A, de Alarcón PA. Fernández KS, et al. Among authors: de alarcon pa. Pediatr Blood Cancer. 2017 Dec;64(12):10.1002/pbc.26681. doi: 10.1002/pbc.26681. Epub 2017 Jun 14. Pediatr Blood Cancer. 2017. PMID: 28612375 Free PMC article.
91 results